The largest database of trusted experimental protocols

Anti cd24 fitc and anti cd44 apc monoclonal antibodies

Manufactured by BD
Sourced in United States

Anti-CD24-FITC and anti-CD44-APC monoclonal antibodies are laboratory reagents used for the detection and analysis of CD24 and CD44 cell surface markers in flow cytometry applications. The anti-CD24-FITC antibody is conjugated to the fluorescent dye FITC, while the anti-CD44-APC antibody is conjugated to the APC fluorophore. These antibodies can be used to identify and characterize cell populations expressing the CD24 and CD44 proteins.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using anti cd24 fitc and anti cd44 apc monoclonal antibodies

1

Apoptosis and Cancer Stem Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Apoptosis was measured by flow cytometry using the Apoptosis-PE Kit with Annexin V. Subpopulation of cancer stem cells was labeled as CD44+/CD24− using anti-CD24-FITC and anti-CD44-APC monoclonal antibodies (Becton Dickinson Biosciences, San Jose, CA, USA). Prostate cancer cells DU145 and PC3 (5 × 104/mL) were seeded in 24-well plates for 24 h and then exposed to TRAIL in concentration of 100 ng/mL and/or one of the taxanes (paclitaxel, docetaxel or cabazitaxel) for 48 h. After this time the cells were harvested using trypsin and ethylenediaminetetracetic acid (EDTA), then washed twice with phosphate-buffered saline (PBS) solution and resuspended in 1× Binding Buffer (100 µL). The cell suspension was incubated with Annexin V-PE (5 µL), anti-CD24-FITC (20 µL) and anti-CD44-APC (20 µL) monoclonal antibodies for 20 min at 4 ℃ in the dark. After this time 400 µL of 1× Binding Buffer was added to each tube. The cells were analyzed by flow cytometry (LSR II, Becton Dickinson Biosciences, San Jose, CA, USA) within 1 h.
+ Open protocol
+ Expand
2

Identifying Cancer Stem Cells in Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD44+/CD24− subpopulation of cancer stem cells was labeled using anti-CD24-FITC and anti-CD44-APC monoclonal antibodies (Becton Dickinson Biosciences, San Jose, CA, USA). Prostate cancer cells DU145 and PC3 (5×104/mL) were seeded in 24-well plates for 24 h and then exposed to TRAIL in concentration of 100 ng/mL and/or one of the taxanes (paclitaxel, docetaxel or cabazitaxel) for 48 h. After this time the cells were harvested using trypsin and ethylenediaminetetracetic acid (EDTA) and then washed twice with phosphate-buffered saline (PBS) solution and resuspended in PharmingenStain Buffer with BSA (100 µL) (Becton Dickinson Biosciences, San Jose, CA, USA). Then the cell suspension was incubated with anti-CD24-FITC (20 µL) and anti-CD44-APC (20 µL) monoclonal antibodies for 20 minutes in the dark. Cells in separate tubes treated with mouse IgG1 APC and IgG2a FITC monoclonal antibody constituted the isotype controls (Becton Dickinson Biosciences, San Jose, CA, USA). After incubation, 400 µL of PharmingenStain Buffer (BSA) was added to each tube. Finally, the cells were analyzed by flow cytometry (LSR II, Becton Dickinson Biosciences, San Jose, CA, USA) within 1 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!